SAN DIEGO, April 2, 2008 /PRNewswire/ -- Naviscan PET Systems, a privately held company specializing in the development of high-resolution PET scanners, announced today that a contract has been signed to place a scanner on-site at The University of Texas M. D. Anderson Cancer Center in Houston. Naviscan's PEM Flex(TM) Solo II system is 510(k) cleared and has been sold commercially since the second quarter of 2007.
M. D. Anderson is planning to use the scanner to further explore current clinical indications and to monitor response to neoadjuvant therapy in breast cancer patients.
"We are extremely excited about the opportunity to be working with a world-renowned cancer center on the application and use of our unique, leading edge molecular imaging technology in quantifying the effectiveness of cancer therapy," said Paul J. Mirabella, Chairman and CEO.
About Naviscan PET Systems, Inc.
Naviscan PET Systems, founded in 1995, designs and develops compact, high-resolution PET scanners that are intended to provide organ-specific imaging, guide radiological and surgical procedures. Naviscan has developed the PEM Flex(TM) Solo II, a high-resolution PET scanner designed to image small body parts such as the breast. PEM Flex(TM) is utilized in clinical research studies, funded in part by the National Institutes of Health. The Company is headquartered in San Diego, California. http://www.naviscanpet.com
|SOURCE Naviscan PET Systems, Inc.|
Copyright©2008 PR Newswire.
All rights reserved